SAROJASpecialty Chemicals
Saroja Pharma Indus Ind L — Cash Flow Statement
₹28.00
+0.00%
Saroja Pharma Indus Ind L Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | -3.70 Cr | -2.54 Cr | -3.98 Cr | -1.10 Cr |
| Repayment Of Debt | -4.45 Cr | — | — | — |
| Issuance Of Debt | 0.92 Cr | 4.05 Cr | 3.12 Cr | 1.35 Cr |
| Issuance Of Capital Stock | 8.68 Cr | 0.00 | 1.95 Cr | 0.00 |
| Capital Expenditure | -4.73 Cr | -4.73 Cr | -0.31 Cr | -0.05 Cr |
| End Cash Position | 0.32 Cr | 0.36 Cr | 0.26 Cr | 41000.00 |
| Beginning Cash Position | 0.36 Cr | 0.26 Cr | 41000.00 | 0.08 Cr |
| Changes In Cash | -0.04 Cr | 0.10 Cr | 0.26 Cr | -0.07 Cr |
| Financing Cash Flow | 3.70 Cr | 2.73 Cr | 4.27 Cr | 1.03 Cr |
| Net Other Financing Charges | -1000.00 | — | — | — |
| Interest Paid Cff | -1.45 Cr | -1.32 Cr | -0.80 Cr | -0.33 Cr |
| Net Common Stock Issuance | 8.68 Cr | 0.00 | 1.95 Cr | 0.00 |
| Common Stock Issuance | 8.68 Cr | 0.00 | 1.95 Cr | 0.00 |
| Net Issuance Payments Of Debt | -3.54 Cr | 4.05 Cr | 3.12 Cr | 1.35 Cr |
| Net Long Term Debt Issuance | -3.54 Cr | 4.05 Cr | 3.12 Cr | 1.35 Cr |
| Long Term Debt Payments | -4.45 Cr | — | — | — |
| Long Term Debt Issuance | 0.92 Cr | 4.05 Cr | 3.12 Cr | 1.35 Cr |
| Investing Cash Flow | -4.76 Cr | -4.82 Cr | -0.34 Cr | -0.05 Cr |
| Interest Received Cfi | 0.02 Cr | 0.01 Cr | 99000.00 | 41000.00 |
| Net Investment Purchase And Sale | -0.06 Cr | -0.10 Cr | -0.04 Cr | 0.00 |
| Purchase Of Investment | -0.06 Cr | -0.10 Cr | -0.04 Cr | 0.00 |
| Net PPE Purchase And Sale | -4.73 Cr | -4.73 Cr | -0.31 Cr | -0.05 Cr |
| Purchase Of PPE | -4.73 Cr | -4.73 Cr | -0.31 Cr | -0.05 Cr |
| Operating Cash Flow | 1.02 Cr | 2.19 Cr | -3.67 Cr | -1.05 Cr |
| Taxes Refund Paid | -0.33 Cr | -0.42 Cr | -0.44 Cr | -0.30 Cr |
| Change In Working Capital | -1.37 Cr | -0.25 Cr | -5.65 Cr | -2.13 Cr |
| Change In Other Current Liabilities | 0.55 Cr | 0.15 Cr | -0.08 Cr | -0.02 Cr |
| Change In Other Current Assets | 0.17 Cr | -0.63 Cr | -0.16 Cr | -0.15 Cr |
| Change In Payable | -0.25 Cr | 0.56 Cr | 1.15 Cr | 1.40 Cr |
| Change In Inventory | 3.47 Cr | -3.40 Cr | 0.19 Cr | -0.39 Cr |
| Change In Receivables | -5.13 Cr | 3.07 Cr | -6.76 Cr | -2.96 Cr |
| Other Non Cash Items | 1.42 Cr | 1.31 Cr | 0.79 Cr | 0.33 Cr |
| Depreciation And Amortization | 0.09 Cr | 0.07 Cr | 0.05 Cr | 0.02 Cr |
| Amortization Cash Flow | 9000.00 | 12000.00 | 37000.00 | 19000.00 |
| Depreciation | 0.09 Cr | 0.07 Cr | 0.04 Cr | 0.02 Cr |
| Net Income From Continuing Operations | 1.21 Cr | 1.49 Cr | 1.58 Cr | 1.04 Cr |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | — | — |
| Net Other Investing Changes | — | — | -1000.00 | -1000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Saroja Pharma Indus Ind L
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.